enGene Therapeutics (ENGN) vs Greenland Mines (GRML)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
enGene Therapeutics (ENGN) has outperformed Greenland Mines (GRML) over the past year, losing 75.1% versus a loss of 80.4%. enGene Therapeutics is the larger company by market cap ($116.9 million vs $77.8 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ENGN | GRML |
|---|---|---|
| Share price | $1.75 | $5.83 |
| Market cap | $116.94M | $77.81M |
| 1-day change | -3.06% | -8.62% |
| YTD return | -80.68% | -59.65% |
| 1-year return | -75.11% | -80.37% |
| EPS (TTM) | $-2.00 | $-9.74 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.25 | $37.00 |
| 52-week low | $1.40 | $2.82 |
| Distance from 52-week high | -85.76% | -84.24% |
| Average volume | 759.27K | 7.99M |
| Shares outstanding | 67.02M | 13.35M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ENGN vs GRML FAQ
Which is bigger, enGene Therapeutics or Greenland Mines?
enGene Therapeutics (ENGN) is larger, with a market capitalization of $116.94M compared with $77.81M for Greenland Mines (GRML).
Which stock has performed better over the past year, ENGN or GRML?
ENGN returned -75.11% over the past 12 months, compared with -80.37% for GRML (price return, excluding dividends). Past performance does not predict future results.
Are enGene Therapeutics and Greenland Mines in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.